Newsroom, your daily review

Keep up with the latest in the tableting community!


Showing posts tagged as : #scale-up

Press review

pharmaceutical-technology

April 1, 2022

Meet the company on a mission to revolutionise tableting scale-up

Let's discover MEDELPHARM, a campany specialized in solutions for drug development process for solid dose pharmaceutical product. All processes are concerned, including "extensive formulation development, preclinical testing and clinical trials..."

Click here for full article.

#STYL'One Nano #scale-up #Medelpharm #development

Press review

MySTYL'One

Jan. 9, 2022

Characterization of tableting speed-dependent deformation properties of active pharmaceutical ingredients in powder mixtures using out-of-die method

The paper highlights an evaluation method to determine the effect of speed during tableting on the compression properties of pharmaceutical powders (APIs mixed with excipients).

Different tests were conducted to determine viscoelasticity, stress relaxation, followed by compaction on both STYL’One compaction simulator and a rotary press. Results show that the sensitivity of the out-of-die SRS was higher than that of in-die SRS.


Full results available in the paper, head to the “Papers” section of...

The paper highlights an evaluation method to determine the effect of speed during tableting on the compression properties of pharmaceutical powders (APIs mixed with excipients).

Different tests were conducted to determine viscoelasticity, stress relaxation, followed by compaction on both STYL’One compaction simulator and a rotary press. Results show that the sensitivity of the out-of-die SRS was higher than that of in-die SRS.


Full results available in the paper, head to the “Papers” section of MySTYL'One (members only).

#scale-up #viscoelasticity #'strain rate sensitivity' #'tableting speed' #'out-of-die' #'compression'

Press review

MySTYL'One

Dec. 1, 2021

Exploring bilayer tablet manufacturing

Article published on Pharmaceutical Online that reviews selecting this specific dosage form, manufacturing challenges and how to overcome them, considerations for evaluating a CDMO, and the typical timeframe for scale-up.
Access the news HERE

#multilayer #Q&A #scale-up #bilayer

Publish with us!